You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5389 Results
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Document
Oct 2017
Statistical Reports
Oct 2017
Guidelines and Advice
Status: Current
ID: GL-C50-33
Version: 1
Aug 2017
Regimen
Cancer Type:
Skin, 
Merkel Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    etoposide - oral capsules
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PACLitaxel,
CARBOplatin,
etoposide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020

Pages